Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class
Koraćević, Goran
Koraćević, Maja
Stojanović, Milovan
Micić, Slađana
Beta-blockers (BBs) are an important class of drugs, with numerous indications in cardiology, emergency and general medicine. The indications include heart failure (HF), acute myocardial infarction (AMI), post-MI , supraventricular and ventricular arrhythmias, chronic coronary syndrome, systemic arterial hypertension (HTN), hypertrophic cardiomyopathy and aortic aneurysm or dissection. All BBs decrease heart rate (HR) and blood pressure (BP), the major determinants of myocardial oxygen consumption; therefore, myocardial anti-ischemic action is a class effect. On the other hand, it is very important that not all BBs decrease all-cause mortality and sudden death; therefore, their crucial characteristics are not the class effect.
Current Vascular Pharmacology, Volume 19, Issue 4, pp.343-346
engleski
2020
Ovo delo je licencirano pod uslovima licence
Creative Commons CC BY-NC-ND 4.0 - Creative Commons Autorstvo - Nekomercijalno - Bez prerada 4.0 International License.
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode